Health Care·Pharmaceuticals·$2.2B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.29 | N/A | -12.91% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.29 | N/A | -12.91% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about market conditions impacting performance. They highlighted ongoing efforts to manage costs and improve efficiency.
Management noted challenges in the current market environment.
They emphasized a focus on cost management and operational efficiency.
There was no specific guidance provided for future quarters.
Phibro Animal Health's earnings report indicates a slight miss on EPS, which may raise concerns among investors about the company's current performance. The stock reacted with a minor decline of 0.13%, reflecting cautious sentiment in the market. The lack of revenue data and guidance adds to the uncertainty surrounding the company's future outlook.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
STRYKER CORP
May 1, 2023